Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis

Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis

Background: Low-dose aspirin lowers cardiovascular event risk; dual-pathway inhibition (DPI) using low-dose aspirin with low-dose rivaroxaban may reduce this risk further. A systematic literature review and meta-analysis compared the efficacy, safety and net clinical benefit (NCB) of DPI with aspiri...

Full description

Bibliographic Details
Main Authors: Dirk Sibbing, Michael J Blaha, Rajinder Chawla, Augusto Lavalle-Cobo, Amit Kishore, Angel Lanas, Li Li, Francesca Santilli, Oliver Schnell, Zhongwei Shi
Format: Article
Language:English
Published: Radcliffe Medical Media 2024-04-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2023.40

Internet

https://www.ecrjournal.com/articleindex/ecr.2023.40

Similar Items